MELBOURNE, AUSTRALIA--(Marketwire - Sep 18, 2012) - Biota Holdings Limited (ASX: BTA) today announced revised terms for the proposed merger with Nabi Biopharmaceuticals.The movement in the Biota ...

Two directors of Melbourne drug developer Biota who oversaw the company's four-year battle with pharmaceuticals giant GlaxoSmithKline have announced they will leave the board following last month ...

Add articles to your saved list and come back to them any time. Anti-infective drug developer Biota is to merge with United States-based Nabi Pharmaceuticals to form a new company that will be ...

Biota shares rose half a cent to 46.5 cents after the announcement. The share price has nearly halved in the past year, in line with the waning fortunes of the company's flagship anti-flu drug ...

Protosterol Biota thrived from about 1.6 billion years ago up until roughly 800 million years ago and were more complex than bacteria. They were also probably larger than bacteria, but scientists ...

Contacts. Investor / Analyst Enquiries Biota Holdings Limited Peter Cook, +61 3 9915 3720 Damian Lismore, +61 3 9915 3721 Media Enquiries Hinton & Associates Nerida Mossop, +61 3 9600 1979 M: +61 ...